Jenny's serves people with high blood pressure, high blood sugar, and high blood lipids through high-tech acupuncture stasis-removing techniques and is seeking seed-round financing.

1. Project Introduction

Jienishi has partnered with a medical technology company on the infrared positioning stasis - clearing technique. This is a method that uses the negative - pressure extraction and acupuncture technology of the medical stasis - clearing treatment device to expel qi stagnation and blood stasis, wind - cold stasis blockage, and diseased tissues from the body. Through this cooperation, it has developed into a chain enterprise serving the general public, helping patients with cervical spondylosis, varicose veins, cerebral thrombosis, cerebral infarction, and cardiovascular and cerebrovascular diseases to recover.

Jienishi's business spans the beauty industry and the large - scale health industry. Its core target audience is the trillion - level health market of people aged 50 - 55, including those with three highs (high blood pressure, high blood sugar, and high blood lipid) and diabetes. It adheres to the theory that for people to become beautiful, in addition to daily care and maintenance, they must be in good health. It aims to help the target population implement the principles of health management, preventive treatment, and pre - maintenance, thereby achieving the goal of increasing people's lifespan.

Jienishi will expand globally in two forms: traditional Chinese medicine clinics and non - drug therapy in the beauty and health industry. The company has accumulated a large number of customer resources after years of operation in the beauty industry. The chain stores operate their own business in the daily market, and at the same time, they send consumers with health needs to the traditional Chinese medicine clinics. The traditional Chinese medicine clinics will share profits with the non - drug therapy stores in the beauty and health industry, thus creating an internal - circulation ecological chain.

2. Current Status of the Health Market and the Amount of Financing

Currently, the growth rate of the domestic large - scale health industry continues to rise, and there is a large supply gap in health management services for the middle - aged and elderly patients with chronic diseases. The existing market players are mainly divided into three categories: traditional medical institutions, Internet medical platforms, and high - end private health centers. These three types of players together account for more than 50% of the market share. Traditional medical institutions have the advantages of technology and trust, but generally face problems such as high pressure on medical treatment and lack of personalized services. Internet medical platforms have a wide coverage, but lack the ability to implement offline intervention. High - end private health centers offer good service experiences, but their high prices make it difficult to cover the general public. The differential advantage of Jienishi Chain lies in relying on the technology and scientific research capabilities of the core team. Starting from targeted blood vessel stasis clearance, it combines service standardization with affordable prices, filling the market gap for high - quality health management services for the middle - aged and elderly patients with chronic diseases. Currently, the project has completed the early - stage market trial and error, and the core model has been proven and is waiting for large - scale implementation. At present, the brand influence is limited, and consumers may easily mistake the project services for hemodialysis - related medical treatments, which is the core problem to be solved for the large - scale promotion of the project. Based on the current performance of the medical stasis - clearing treatment device in the market, the monthly performance of a single unit is 2 - 5 million RMB, indicating a huge market prospect. Previously, Jienishi Chain has never conducted external financing, and this is the first time it publicly raises funds from the capital market. The project needs to raise 15 million RMB.

3. Core Team Members

The core members of the team have both a scientific and technological background and expertise in the beauty and health fields. Peng Yusi, a co - founder, has worked in first - tier Internet companies such as Yahoo Research and AngelCrunch. He is also a co - founder of the startup service platform IT Juzi, and has led the development of products such as the first version of China Unicom WeChat and the core database of IT Juzi. Another co - founder, Zheng Dongming, is the founder and chairman of Xingfuhui Consulting. He is the author of the best - selling book "Performance Partnership" and a practical tutor for the Performance Partnership 573 system. He has 20 years of in - depth service experience for growing enterprises, serving more than 30,000 enterprises in total, and the radiation effect on enterprise benefit growth exceeds 50 billion RMB. The other core members have expertise in scientific and technological skin care and non - drug therapies. Peng Yusi has many years of software development experience. Xiang Shangbin has more than 20 years of experience in physical chain enterprises and the Internet industry, and has natural advantages in polishing the business model of startup projects and resource docking. Zheng Dongming has been deeply involved in enterprise consulting services for 20 years and has a mature methodology for building the mechanism of the chain business and empowering the team. The combination of the three has laid a solid foundation for the development of Jienishi Chain. As the aging of the domestic population deepens, the demand for health management of chronic diseases among the middle - aged and elderly over 50 continues to grow. An offline health service chain with both professional capabilities and affordable prices is expected to find a differential path in the fragmented large - scale health market. Relying on the core technology of targeted blood vessel clearance, Jienishi Chain is opening up a new track that combines the beauty industry and health management.